NIH scientists pursue new therapies to improve rare disease drug development

(NIH/National Center for Advancing Translational Sciences (NCATS)) Four new preclinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers. (Source: EurekAlert! – Medicine and Health) …read more